Announcements Trials
Browse Landscape

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Uveal Neoplasms 1Uveal Melanoma 1Thyroid Neoplasms 1Sarcoma, Ewing 1Neoplasm Metastasis 1Melanoma 1Iris Neoplasms 1Choroid Neoplasms 1Breast Neoplasms 1

Interventions

Radiosurgery 7Oxaliplatin 7Docetaxel 7Paclitaxel 5Fluorouracil 5Nivolumab 4Magnetic Resonance Spectroscopy 4Gemcitabine 4Carboplatin 4Capecitabine 4Trastuzumab 3Radiotherapy 3Radiation 3Leucovorin 3Erlotinib Hydrochloride 3Cyclophosphamide 3Cetuximab 3Bevacizumab 3spartalizumab 2sipuleucel-T 2repotrectinib 2pembrolizumab 2pazopanib 2orteronel 2fludarabine 2atezolizumab 2aldesleukin 2Temozolomide 2Surveys and Questionnaires 2Sunitinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Neoplasm Metastasis × Biopsy, Fine-Needle × Clear all
NCT00406120 2018-06-26

Validation of a Molecular Prognostic Test for Eye Melanoma

Washington University School of Medicine

Withdrawn
Dermatologic

Uveal Melanoma, Choroid Neoplasms, Melanoma, Neoplasm Metastasis, Uveal Neoplasms, Iris Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡